NCT05592483 2024-11-07
DB RESPOND
AstraZeneca
Terminated
Clinical Trials
4 trialsNCT06126003 2024-08-02
Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.
BioCorteX Inc
Terminated
NCT05032352 2022-11-14
PADMA
Insight Molecular Diagnostics
Terminated
NCT01039376 2019-07-30
PROLONG
Novartis
Phase 3 Terminated